Your Partner for Innovative In-Vitro Diagnostic
Systems Design and Development

From concept to commercial solutions, we develop innovative in-vitro diagnostic systems that allow our customers to get to market faster. Download our LexaGene MiQLab™ case study to see how we helped them pivot their technology for COVID-19 detection.

Download Now

Why Ximedica?

In-vitro diagnostic (IVD) platforms are evolving rapidly around molecular diagnostics, multiplexed formats, automation, and demand for Point-Of-Care technology. While platform value is often dominated by reagents, a full grasp of system (hardware, software, and consumables) architecture and performance is critical to market success.

Our expert team of designers, engineers, and project managers uses a human-centered, integrated development process to create IVD systems that are

thoughtfully designed, approved, manufactured, and ultimately delivered to market.

Innovation Strategy

We employ user-centered design to generate both new and novel solutions with a competitive edge.

End-to-End Capabilities

Our team handles every step of the IVD diagnostic device development process, from concept generation to production and commercial support.

Proven Process

We take a thoughtful, human-centered approach to product development, and our IVD diagnostics product development process has the rigor required by the FDA.

In-Vitro Diagnostics

We offer complex instrument and consumable development, high throughput lab automation, in-vitro diagnostics (IVD) and Point-Of-Care systems.

Partner with Ximedica on your next in-vitro diagnostics program.

DOWNLOAD OUR LEXAGENE MIQLAB™ CASE STUDY TO LEARN MORE.